-
Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi kaiapuni hoʻokele waiwai a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho ma mua o ka pāʻani. Hele mai nā mea hou o waho ma nā ʻano like ʻole a puka mai i nā ʻano like ʻole ...Heluhelu hou aku»
-
Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke koho ʻia ka mutant KRAS, a hōʻike ʻia ʻo ARS-1620 e hōʻike ana i kahi hanauna hou o ...Heluhelu hou aku»
-
Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ʻO ka Anglo-Swedish mea hana lāʻau lapaʻau, a me MedImmune, kāna noiʻi ʻana i nā mea ola honua a me ka de...Heluhelu hou aku»
